Clinical Trials Browser

Unknown × INDUSTRY × Lymphoma, T-Cell, Peripheral × Clear all

NCT03502629 2021-03-03

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04108325 2021-01-28

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT04615468 2020-11-04

A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Phase 1 Unknown

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT04457830 2020-10-22

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02495415 2019-07-23

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT03150602 2017-05-12

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Phase 4 Unknown

Lymphoma, T-Cell, Peripheral, Disease Progression